{"id": "1386460316960051206", "creation": 1619392873.0, "user_id": "41626609", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@timesofindia  Bio E's #Covid19 #vaccine candidate gets #India SEC nod for phase-III trials   -- this is the one from @PeterHotez and colleagues at Baylor  @bcmhouston  https://t.co/c0tP9EovNE", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#INDIA"]}